跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
SUNITINIB CIPLA 12,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
SUNITINIB CIPLA 12,5 MG CAPSULAS DURAS EFG
Cipla Europe
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2020
Approval ID
fc2ca44833e1a3fa
Company
Cipla Europe
Type
Standard
Approval Details
Approval Id
fc2ca44833e1a3fa
Drug Cima Aemps Name
SUNITINIB CIPLA 12,5 MG CAPSULAS DURAS EFG
Register Number
85666
Holder Company Name
Cipla Europe
Marketing Company Name
Cipla Europe Nv Sucursal En Espana
Authorization Date
2020-12-21
Dosage Form
CÁPSULA DURA
Dose
12.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Cipla Europe
Active Ingredients
SUNITINIB MALATO
16,7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2020
Approval ID
fc2ca44833e1a3fa
Type
Standard
Back to CIMA-AEMPS Approvals
SUNITINIB CIPLA 12,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
